Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > The thing is....
View:
Post by sah1 on Jul 03, 2020 9:20am

The thing is....

The company has to raise $75-100M to get to BLA approval. This is likely to be an equity raise as a marketing deal is unlikely in the near future. Nasdaq listing with 20% dilution, at what price?
Comment by realstocky on Jul 03, 2020 9:32am
This post has been removed in accordance with Community Policy
Comment by Dibah42 on Jul 03, 2020 10:00am
If that is the case then why doesn't Clulow lend LMNL $100m from the TV treasury @ 10% ?
Comment by aussyspitz on Jul 03, 2020 1:19pm
Because it will be much easier for them to squeeze the remaining retail investors pockets/wallets via printing more discounted shares to include the possibility of issuing some further discounted  warrants to insiders/instutional investors at the expense of retail investors
Comment by StockReddy on Jul 03, 2020 10:07am
My guess is at rights offer price.
Comment by ualcin1 on Jul 03, 2020 2:27pm
Sah1, you seem to rule out Liminal using its LOC. Why?
Comment by sah1 on Jul 03, 2020 3:32pm
Because of the past history, I feel that the LoC will be used as a measure of last resort. Also, there is a need to improve market liquidity so an equity raise on Nasdaq would fit the bill. 5M shares at US$ 15- 20 would set the company up very well. Alternatively, I wouldn’t mind if Lmnl sold a significant interest of its plasma protein business to a private equity firm with cash upfront and ...more  
Comment by aussyspitz on Jul 03, 2020 11:58pm
By my calculations they could issue up to about 8.73M in a combination of shares and warrants that would give them about a 170M @ $20 and still give TV its 51% shareholder control that would also buy them at least a year and a half to make something happen. On paper it looks at least plausible good luck sah1 hope it works out for you.  
Comment by ualcin1 on Jul 04, 2020 12:49pm
Sah1, apologies for the delay in thanking you for your response. Knowing that Liminal intends to file its amended BLA by September 30, could your analysis take into account that the FDA could award it a PRV and if so, how much might this change, in your mind, the financial landscape of the company?
Comment by sah1 on Jul 05, 2020 2:12pm
The equity raise I am talking about would get Lmnl to Bla approval. If a voucher is granted upon approval this will help the company immensely at that time. It is a big ‘if’ though. 
Comment by ualcin1 on Jul 05, 2020 10:06pm
You're not confident that Liminal deserves a voucher...
Comment by sah1 on Jul 06, 2020 3:43am
I am hopeful and it is clear the company will apply for a voucher when it submits its Bla. Will the FDA grant a voucher is another matter? I don’t know the details of the program so we will have to wait and see.
Comment by ualcin1 on Jul 06, 2020 8:20am
Thanks sah1. Since we are talking about an amended BLA, could the FDA grant the voucher sooner than usual? Is there anyone in this forum who is familiar with these procedures? Because it would be a significant game-changer this year...
Comment by sah1 on Jul 06, 2020 9:30am
As far as I know, a voucher is granted upon approval.
Comment by Dibah42 on Jul 06, 2020 10:26am
I've known you long enough that you won't intentionally mislead but this is potentially misleading. A very very very miniscule minority qualify for a Priority Voucher.   Details of the prog are to be found at the FDA site for those interested.
Comment by sah1 on Jul 06, 2020 12:40pm
If you follow the trail, Dibsh you will note that I used the word ‘if’ when talking of the voucher
Comment by foofadooo on Jul 06, 2020 11:10am
PRV info...... Page 17......   https://www.fda.gov/media/112176/download foof
Comment by GunnerG on Jul 06, 2020 11:42am
Interesting is Page 19 where they talk about "Future?" and then mentions "Sunsets - 30 Sept 2016 altough legislation may be extended until 31 December 2022". Was the program cancelled?
Comment by ualcin1 on Jul 06, 2020 11:21am
True.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities